AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

64 hedge funds and large institutions have $195M invested in Autolus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 14 closing their positions.

Holders
64
Holders Change
-6
Holders Change %
-8.57%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
20
Reduced
11
Closed
14
Calls
$72K
Puts
$13K
Net Calls
+$59K
Net Calls Change
-$272K

Top Buyers

1
PL
1
Perpetual Ltd
Australia
$3.42M
2
TAM
2
TFG Asset Management
Cayman Islands
$18.4M
3
UOC
3
UBS O'Connor
Illinois
$1.39M
4
BlackRock
4
BlackRock
New York
$1.63M
5
Millennium Management
5
Millennium Management
New York
$663K

Top Sellers

1
CH
1
CVI Holdings
Delaware
$0
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$394K
3
Capital World Investors
3
Capital World Investors
California
$0
4
AC
4
Armistice Capital
New York
$17.8M
5
SFM
5
Sphera Funds Management
Israel
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
76
Group One Trading
Illinois
– – -2,700 Closed
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
– – -293 Closed
Citigroup
78
Citigroup
New York
– – -92 Closed
CFGS
79
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
80
Simplex Trading
Illinois
– – – –
1 2 3
4